Valiant Laboratories (NSE:VALIANTLAB) Price-to-Tangible-Book: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VALIANTLAB Valiant Laboratories Ltd NSE:VALIANTLAB
53 GF Score
Price ₹127.08
GF Value ₹127.68
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Valiant Laboratories Price-to-Tangible-Book?

As of today (2026-09-22), Valiant Laboratories's share price is ₹127.08. Valiant Laboratories's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was . Hence, Valiant Laboratories's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Valiant Laboratories's Price-to-Tangible-Book or its related term are showing as below:

NSE:VALIANTLAB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.9   Med: 1.42   Max: 2.67
Current: 2.21

During the past 6 years, Valiant Laboratories's highest Price to Tangible Book Ratio was 2.67. The lowest was 0.90. And the median was 1.42.

NSE:VALIANTLAB's Price-to-Tangible-Book is ranked better than
53.75% of 839 companies
in the Drug Manufacturers industry
Industry Median: 2.32 vs NSE:VALIANTLAB: 2.21

A closely related ratio is called PB Ratio. As of today, Valiant Laboratories's share price is ₹127.08. Valiant Laboratories's Book Value per Sharefor the quarter that ended in Jun. 2026 was . Hence, Valiant Laboratories's P/B Ratio of today is .


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Valiant Laboratories Price-to-Tangible-Book Related Terms


Valiant Laboratories Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Valiant Laboratories's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valiant Laboratories Price-to-Tangible-Book Chart

Valiant Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Price-to-Tangible-Book
Get a 7-Day Free Trial - - 2.66 1.42 0.90

Valiant Laboratories Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.40 - 0.90 -

NSE:VALIANTLAB vs ZTS: Price-to-Tangible-Book Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valiant Laboratories Price-to-Tangible-Book vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Valiant Laboratories's Price-to-Tangible-Book falls into.


NSE:VALIANTLAB
53GF Score
Valiant Laboratories Ltd NSE:VALIANTLAB
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valiant Laboratories Price-to-Tangible-Book Calculation

Valiant Laboratories's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=127.08/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Valiant Laboratories (NSE:VALIANTLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Valiant Laboratories stock appears to be undervalued. The current stock price of ₹127.08 is trading 0.5% below its estimated GF Value™ of ₹127.68. GuruFocus considers Valiant Laboratories to be Fairly Valued.

Key valuation signals for NSE:VALIANTLAB:

  • Price-to-Tangible-Book:
  • GF Value™: ₹127.68 vs. price of ₹127.08 (0.5% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the NSE:VALIANTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valiant Laboratories Business Description

Other Exchanges 543998:India
Address Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
53GF Score

Get the complete analysis for NSE:VALIANTLAB

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹127.08
Price
₹127.68
GF Value